We serve Chemical Name:3-Methyl-5-phenylisoxazole-4-carboxylic acid CAS:17153-21-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Methyl-5-phenylisoxazole-4-carboxylic acid
CAS.NO:17153-21-8
Synonyms:3-Methyl-5-phenyl-4-isoxazolecarboxylic acid;3-methyl-5-phenyl-1,2-oxazole-4-carboxylic acid
Molecular Formula:C11H9NO3
Molecular Weight:203.19400
HS Code:2934999090
Physical and Chemical Properties:
Melting point:191ºC
Boiling point:362.1ºC at 760mmHg
Density:1.273g/cm3
Index of Refraction:1.579
PSA:63.33000
Exact Mass:203.05800
LogP:2.34820
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Methyl-5-phenyl-4-isoxazolecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methyl-5-phenyl-1,2-oxazole-4-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methyl-5-phenyl-4-isoxazolecarboxylic acid Use and application,3-Methyl-5-phenyl-4-isoxazolecarboxylic acid technical grade,usp/ep/jp grade.
Related News: Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 3-Methyl-5-phenylisoxazole-4-carboxylic acid manufacturer APIs are generally manufactured through a variety of processes that include. 3-Methyl-5-phenylisoxazole-4-carboxylic acid supplier Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 3-Methyl-5-phenylisoxazole-4-carboxylic acid vendor Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. 3-Methyl-5-phenylisoxazole-4-carboxylic acid factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.
